No. 84-2, June 2022

Index

• Balance and Standardization: Implications for Competition and Antitrust Analysis
• The Neglected Concern of Firm Size in Pharmaceutical Mergers
• Collusion in Plain Sight: Firms' Use of Public Announcements to Restrain Competition
• Replacing the Structural Presumption
• The Role of Efficiency Evidence in Price-Fixing Litigation
• Editors' Note
• The Illinois Brick Damages Edifice: Demolition or Deconstruction?
• Unintended Consequences of Repealing the Direct Purchaser Rule
• Let's Talk About Consumers: Competition Law Compensation for Indirect Purchasers' Losses-A United Kingdom Perspective